LCM
TMDX icon

Legato Capital Management’s Transmedics TMDX Stock Holding History

Legato Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,735
Closed -$1.91M – 879
2025
Q4 		$1.91M Buy
15,735
+5,170
+49% +$649K 0.16% 192
2025
Q3 		$1.19M Buy
10,565
+3,905
+59% +$457K 0.13% 247
2025
Q2 		$893K Buy
6,660
+1,730
+35% +$190K 0.11% 308
2025
Q1 		$332K Buy
+4,930
New +$339K 0.04% 475
2024
Q4 		– Sell
-10,391
Closed -$1.63M – 620
2024
Q3 		$1.63M Sell
10,391
-3,570
-26% -$550K 0.2% 160
2024
Q2 		$2.1M Sell
13,961
-86
-0.6% -$10.3K 0.28% 96
2024
Q1 		$1.04M Sell
14,047
-3,880
-22% -$320K 0.13% 264
2023
Q4 		$1.41M Buy
17,927
+11,113
+163% +$670K 0.18% 173
2023
Q3 		$373K Sell
6,814
-30,529
-82% -$2.2M 0.05% 456
2023
Q2 		$3.14M Buy
37,343
+4,264
+13% +$326K 0.42% 45
2023
Q1 		$2.51M Hold
33,079
– – 0.46% 43
2022
Q4 		$2.04M Buy
+33,079
New +$1.76M 0.39% 62

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legato Capital Management's TMDX Position: Q1 2026 in Review

Legato Capital Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 15,735 shares — an estimated $1.91M sold.

Legato Capital Management first reported a position in TMDX in Q4 2022 and held it in 12 quarters. The position peaked at $3.14M in Q2 2023. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Legato Capital Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Legato Capital Management sold 15,735 Transmedics shares in Q1 2026, an estimated $1.91M.
  • Legato Capital Management first reported a position in Transmedics in Q4 2022 and held it in 12 quarters.
  • Legato Capital Management's Transmedics position peaked at $3.14M in Q2 2023.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.